Adding bevacizumab to single-agent chemotherapy for the treatment of platinum-resistant recurrent ovarian cancer: A cost-effectiveness analysis of the AURELIA trial

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Wysham, WZ; Schaffer, EM; Coles, TM; Roque, DR; Wheeler, SB; Kim, KH

Published Date

  • June 2016

Published In

Volume / Issue

  • 141 /

Start / End Page

  • 36 - 36

Published By

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2016.04.116

Language

  • en